Connor, Clark & Lunn Investment Management »

Xeris Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $237k 83k 2.85
2022-03-31 $74k 29k 2.56

More positions owned by Connor, Clark & Lunn Investment Management

Rbc Cad (RY)
Cibc Cad (CM)
Toronto Dominion Bk Ont Com New (TD)
Enbridge (ENB)
Agnico (AEM)
Canadian Natl Ry (CNI)
Thomson Reuters Corp. (TRI)
Shopify Cl A (SHOP)
Bk Nova Cad (BNS)
Canadian Pacific Kansas City (CP)
Suncor Energy (SU)
Waste Connections (WCN)
Canadian Natural Resources (CNQ)
Manulife Finl Corp (MFC)
Tc Energy Corp (TRP)

View all positions for Connor, Clark & Lunn Investment Management

Top funds holding Xeris Pharmaceuticals

BlackRock
BlackRock
Vanguard Group
MPM Oncology Impact Management
CenterBook Partners
Geode Capital Management
State Street Corporation
Rosalind Advisors
AIGH Capital Management
Morgan Stanley
Renaissance Technologies
Nuveen Asset Management
Northern Trust
AQR Capital Management
Redmile Group

View all funds holding Xeris Pharmaceuticals